1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Kangtai Biological Products Co., Ltd.
  6. Summary
    300601   CNE100002Q33

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-08
34.67 CNY   -1.51%
07/25Kangtai Biological Sees Up to 70% Profit Slump in H1
MT
05/27Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on 2 June 2022
CI
05/23Shenzhen Kangtai Biological Products Co., Ltd. Approves Final Cash Dividend for the Year 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
32.53 33.2 35.28 35.2 34.67 Last
14175500 11534400 18240490 12846600 9244147 Volume
+0.81% +2.06% +6.27% -0.23% -1.51% Change
Estimated financial data (e)
Sales 2022 4 631 M 686 M 686 M
Net income 2022 1 514 M 224 M 224 M
Net cash position 2022 2 576 M 381 M 381 M
P/E ratio 2022 25,6x
Yield 2022 1,06%
Sales 2023 5 887 M 872 M 872 M
Net income 2023 2 156 M 319 M 319 M
Net cash position 2023 1 731 M 256 M 256 M
P/E ratio 2023 17,9x
Yield 2023 1,45%
Capitalization 38 522 M 5 705 M 5 705 M
EV / Sales 2022 7,76x
EV / Sales 2023 6,25x
Nbr of Employees 2 445
Free-Float 48,8%
More Financials
Company
Shenzhen Kangtai Biological Products Co. specialises in the research, development and marketing of human vaccines. Products include vaccines against hepatitis B, haemophilus influenzae type B, measles and rubella. 
Sector
Pharmaceuticals
Calendar
08/25Earnings Release
More about the company
Ratings of Shenzhen Kangtai Biological Products Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
07/25Kangtai Biological Sees Up to 70% Profit Slump in H1
MT
05/27Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend for the Ye..
CI
05/23Shenzhen Kangtai Biological Products Co., Ltd. Approves Final Cash Dividend for the Yea..
CI
05/06UBS Adjusts Shenzhen Kangtai Biological Products' Price Target to 116 Yuan From 125 Yua..
MT
04/28Kangtai Biological's 2021 Profit Surges 86% on Robust Sales
MT
04/28Shenzhen Kangtai Biological Products Co., Ltd. Announces Final Cash Dividend Proposal f..
CI
04/27Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the First Q..
CI
04/14Kangtai Biological's Q1 Profit Seen Soaring 11-Fold on Strong Sales
MT
04/13Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Full Ye..
CI
03/21Shenzhen Kangtai Biological Products Co., Ltd Signs Framework Agreement with Phil.Pharm..
CI
2021China accelerating research into COVID-19 shots targeting Omicron - state media
RE
2021Shenzhen Kangtai Biological Products Co., Ltd. Announces Export of Kangtai Adenovirus V..
CI
2021AstraZeneca's Chinese Distributor Sends First Vaccine Shipment To Indonesia
MT
2021China's BioKangtai begins first shipment of AstraZeneca's COVID-19 shot
RE
2021National Agency of Drug and Food Control Grants the Emergency Use Authorization for Cov..
CI
More news
News in other languages on SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
07/25Kangtai Biological enregistre une chute de ses bénéfices de 70 % au premier semestre.
05/27Shenzhen Kangtai Biological Products Co., Ltd. annonce un dividende final en espèces po..
05/23Shenzhen Kangtai Biological Products Co., Ltd. approuve le dividende final en espèces p..
04/28Le bénéfice de Kangtai Biological en 2021 a bondi de 86 % grâce à des ventes robustes.
04/28Shenzhen Kangtai Biological Products Co., Ltd. annonce une proposition finale de divide..
More news
Analyst Recommendations on SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
More recommendations
Chart SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Shenzhen Kangtai Biological Products Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 34,67 CNY
Average target price 56,45 CNY
Spread / Average Target 62,8%
EPS Revisions
Managers and Directors
Wei Min Du Chairman & General Manager
Xiang Miao Chief Financial Officer & Board Secretary
Zhi Yun Lu Chairman-Supervisory Board
Xiang Ming Li Independent Director
Dong Guang Ma Independent Director
Sector and Competitors